Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of Cardiovascular Events and Mortality: A Meta-Analysis

Overview of attention for article published in Frontiers in endocrinology, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 15,579 followers.

"Although ASA has no significant risk on primary endpoints of CV events and bleeding outcomes in patients with DM compared to control, #MACE were significantly lower in the ASA group" OR 0.91 (0.84 to 0.99) https://t.co/bybAD9WqQH

07 Sep 2021

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of C…

01 Sep 2021

Reply Repost Favourite

New Research: Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of Cardiovascular Events and Mortality: A Meta-Analysis: Purpose A meta-analysis was conducted to assess the benefits… https://t.co/v7HxWBxTBg

01 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.